Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.02 USD | +4.37% | +4.39% | +6.38% |
Sales 2024 * | 279B 3.35B | Sales 2025 * | 299B 3.59B | Capitalization | 1,035B 12.43B |
---|---|---|---|---|---|
Net income 2024 * | 54.64B 656M | Net income 2025 * | 56.74B 681M | EV / Sales 2024 * | 3.48 x |
Net cash position 2024 * | 66.43B 797M | Net cash position 2025 * | 105B 1.26B | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
18.2
x | Employees | 25,863 |
Yield 2024 * |
0.66% | Yield 2025 * |
0.71% | Free-Float | 91.52% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | +4.37% | ||
1 week | +4.39% | ||
Current month | +0.91% | ||
1 month | +0.83% | ||
3 months | +6.55% | ||
6 months | +11.96% | ||
Current year | +6.38% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
Chairman | 56 | 93-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 07-06-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.69% | 96 M€ | -.--% | - | |
1.76% | 11 M€ | -.--% | - | |
0.56% | 18 M€ | +2.98% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 74.02 | +4.37% | 478,273 |
24-04-24 | 70.92 | -0.80% | 149,246 |
24-04-23 | 71.49 | -0.91% | 132,242 |
24-04-22 | 72.15 | +1.42% | 157,926 |
24-04-19 | 71.14 | +0.32% | 116,991 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.73% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.13% | 233B | |
+5.37% | 201B | |
-9.86% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- DRREDDY Stock
- RDY Stock